Premium
Use of health‐related quality of life in prescribing research. Part 1: why evaluate health‐related quality of life?
Author(s) -
Calvert M. J.,
Freemantle N.
Publication year - 2003
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1046/j.0269-4727.2003.00521.x
Subject(s) - quality of life (healthcare) , medicine , perspective (graphical) , health related quality of life , disease , quality (philosophy) , health technology , clinical practice , alternative medicine , family medicine , health care , nursing , pathology , computer science , philosophy , epistemology , artificial intelligence , economics , economic growth
Summary Clinicians, regulatory authorities, and pharmaceutical companies increasingly recognize the importance of assessing the patient's perspective on the impact of disease and its treatment on their health‐related quality of life (HRQoL). This article describes the importance of assessing HRQoL, particularly in patients with chronic disease, provides examples of the different types of instrument available for measuring HRQoL and considers how such assessment can aid medical‐decision making. In addition we consider the potential role of HRQoL assessment in routine clinical practice, and its use in licensing and health technology appraisal.